Cleared Traditional

K251258 - MC2 Two-Stage Venous Cannula

Also marketed or referenced as:
MC2X™ Three-Stage Venous Cannula

K251258 is the FDA 510(k) clearance for MC2 Two-Stage Venous Cannula by Medtronic, Inc.. It is a Class 2 Cardiovascular device (product code DWF) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K251258 · Medtronic, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
58d
Days
Class 2
Risk

K251258 is an FDA 510(k) clearance for the MC2™ Two-Stage Venous Cannula. Classified as Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (product code DWF), Class II - Special Controls.

Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on June 20, 2025 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic, Inc. devices

Submission Details

510(k) Number K251258 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 2025
Decision Date June 20, 2025
Days to Decision 58 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 125d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass

All 229
Devices cleared under the same product code (DWF) and FDA review panel - the closest regulatory comparables to K251258.
AngioVac Cannula
K253106 · AngioDynamics, Inc. · Oct 2025
RAP Femoral Venous Cannulae
K250283 · LivaNova USA, Inc. · Jul 2025
Easyflow (103-200
K250610 · Sorin Group Italia S.R.L. · Jun 2025
Quantum Perfusion Dual Lumen Cannula 31F-V1 (DL31F-V1)
K241248 · Spectrum Medical S.R.L. · May 2024
R501 - R502 aortic root cannulae with and without vent line (R501-15: R501-20: R501-26. R502-15
K240193 · Sorin Group Italia S.R.L. · Feb 2024
EZ Glide Aortic Perfusion Cannulae (EZC21A, EZC21TA, EZC24A, EZC24TA, EZF21A, EZF21TA, EZF24A, EZF24TA, EZS21A, EZS21TA, EZS24A and EZS24TA)
K233895 · Edwards Lifesciences · Feb 2024